Talus 40SC Insect Growth Regulator

SECTION 2: Hazards identification

OSHA EMERGENCY OVERVIEW Off-white, viscous liquid. WARNING Causes substantial but temporary eye injury. Causes moderate skin irritation.

Principle Routes of Exposure

Skin contact Signs and Symptoms of Overexposure: Symptoms from excessive ingestion of Buprofezin Technical may include subdued mood, slight muscular incoordination, and a slightly enlarged abdomen.

Potential health effects

Avoid contact with skin, eyes, and clothing. Eye Contact: Contact with this product causes mild but reversible eye irritation. Ingestion: No specific health effects are known for ingestion of a small amount incidental to routine handling and use. Ingestion of large amounts may be harmful (See Signs and Symptoms of Overexposure above). Inhalation: Inhalation of this product is harmful. The active ingredient (buprofezin technical) is not known to be a significant irritant to the respiratory system, but excessive dust inhalation of the inert ingredients in a confined area may cause irritation and congestion of the upper respiratory tract. Skin Contact: Absorption through the skin is harmful. This product is a moderate skin irritant but not a skin sensitizer. Delayed/Long Term Effects: Carcinogenic: None of the product ingredients are listed as carcinogenic by NTP, IARC, or OSHA. Talus is a registered trademark of Nichino America, Inc. © Copyright 2008 SePRO Corporation. SINGLE OR MIXED PRODUCT: Mixed CHEMICAL NAME(S): • 2-tert-butylimino-3-isopropyl-5-phenylperhydro-1,3,5- thiadiazin-4-one (IUPAC) • 2-[(1,1-dimethylethyl)imino]tetrahydro-3-(1-methylethyl)-5- phenyl-4H-1,3,5-thiadiazin-4-one (CA) CHEMICAL FORMULA: C16H23N3OS INGREDIENTS CAS NO. % Buprofezin Technical 69327-76-0 40% Other Ingredients 60%